Topics
Glioblastoma | Treatment | Immunotherapy | Viruses
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Viruses
*Rossmeisl JH, King JN, Robertson JL, Weger-Lucarelli J,
Elankumaran S.
Phase I/II Trial of
Urokinase Plasminogen Activator-Targeted Oncolytic Newcastle
Disease Virus for Canine Intracranial Tumors.
Cancers
(Basel). 2024 Jan 29;16(3):564. doi:
10.3390/cancers16030564. PMID:
38339315. Interventional animal study. ˍ
Calderón-Peláez MA, Maradei Anaya SJ,
Bedoya-Rodríguez IJ, González-Ipuz KG, Vera-Palacios
D, Buitrago IV, Castellanos JE, Velandia-Romero ML.
Zika
Virus: A Neurotropic Warrior against High-Grade Gliomas-Unveiling
Its Potential for Oncolytic Virotherapy.
Viruses.
2024 Apr 3;16(4):561. doi:
10.3390/v16040561. PMID:
38675903;. Review. ˍ
Kim S, Jung BK, Kim J, Jeon JH, Kim M, Jang SH, Kim CS, Jang H.
Anticancer effect of the oncolytic
Newcastle disease virus harboring the PTEN gene on glioblastoma.
Oncol
Lett. 2024 Oct 16;29(1):6. doi:
10.3892/ol.2024.14752. PMID:
39492938. Laboratory investigation. ˍ
Gunasegaran B, Ashley CL,
Marsh-Wakefield F, Guillemin GJ, Heng B.
Viruses
in glioblastoma:
an update on evidence and clinical trials.
BJC
Rep. 2024 Apr
19;2(1):33. doi:
10.1038/s44276-024-00051-z.
PMID:
39516641. Review. ˍ
Meléndez-Vázquez NM, Gomez-Manzano C, Godoy-Vitorino
F.
Oncolytic
Virotherapies and Adjuvant Gut
Microbiome Therapeutics to Enhance Efficacy
Against Malignant Gliomas.
Viruses.
2024 Nov 14;16(11):1775. doi:
10.3390/v16111775. PMID:
39599889. Review. ˍ